Heart rate variability-based biofeedback in patients after acute COVID-19 disease

Not Applicable

Recruiting

• Conditions: B34.2; Coronavirus infection, unspecified site

• Registration Number: DRKS00028715
• Lead Sponsor: niversitätsklinikum Carl Gustav Carus

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

proof of SARS-CoV-2 infection; clinically remission of a no longer infectious COVID-19 disease; persistent cardiopulmonary symptomatic disease with indication for further inpatient or early rehabilitative therapy

Exclusion Criteria

taking tricyclic antidepressants within 14 days before start of study participation; arrhythmia absoluta; pacemakers; known diabetic or autonomic neuropathy; alcohol dependence; respiratory failure; cognitive deficits or physical limitations with resulting inability to perform biofeedback training

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart rate variability assessed via standard deviation of NN intervals (SDNN)

Secondary Outcome Measures

Name	Time	Method
HRV frequency-, and time domain parameters, sudomotor and vasomotor function as well as degree of COVID-19-associated symptoms